Enzo Biochem Inc was founded in 1976. It is engaged in research, development, manufacturing and marketing of diagnostic and research products based on genetic engineering, biotechnology and molecular biology. The Company develops, manufactures and sells its proprietary technology solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians. The Company's business segments are Enzo Clinical Labs, Enzo Life Sciences, and Enzo Therapeutics. The Enzo Clinical Labs is a clinical reference laboratory provides clinical services to a physicians, medical centers, other clinical labs and pharmaceutical companies. The Enzo Life Sciences manufactures, develops and markets products and tools to clinical research, drug development and bioscience research customers. Underpinned by broad technological capabilities, Enzo Life Sciences has developed proprietary products used in the identification of genomic information by laboratories around the world. The Enzo Therapeutics is a biopharmaceutical venture that has developed multiple novel approaches in the areas of gastrointestinal, infectious, ophthalmic and metabolic diseases, many of which are derived from the pioneering work of Enzo Life Sciences. It owns or license 314 patents relating to products, methods and procedures resulting from its internal or sponsored research projects. The Company distributes its life science products internationally through a network of distributors. It competes with other life science and biotechnology companies, as well as pharmaceutical, chemical and other companies. The Company is subject to licensing and regulation under federal, state and local laws relating to the handling and disposal of medical specimens, infectious and hazardous waste.
Benzinga is a fast-growing, dynamic and innovative financial media outlet that empowers investors with high-quality, unique content.